Albert Bourla, Pfizer CEO (Gian Ehrenzeller/Keystone via AP Images)

When a life-sav­ing vac­cine be­came a cash cow: Pfiz­er now projects $33.5B in Covid-19 vac­cine sales in 2021 alone

As Pfiz­er saves the world right now with its vac­cine, that help isn’t com­ing with­out a mas­sive pay­day for the Big Phar­ma — $33.5 bil­lion in 2021 sales is now the pro­jec­tion.

If Pfiz­er ac­tu­al­ly hits that pro­jec­tion (up from $26 bil­lion in sales the com­pa­ny pre­dict­ed in May), the com­pa­ny will be both hailed as a vic­tor and one of very few rea­sons why the virus could be kept at bay for even a sliv­er of time, and as a prof­i­teer, no mat­ter how much gov­ern­ments around the world have saved with the use of the vac­cine — Pfiz­er may po­ten­tial­ly haul in the great­est sin­gle year’s worth of a phar­ma­ceu­ti­cal or vac­cine’s sales ever.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.